Yonaxis I.P. Law Group Logo
Republic of I.P. Blog | Yonaxis I.P. Law Group
of 41

Second Circuit Will Not Yet Hear Embedded Tweet Appeal

In a somewhat unsurprising move, the Court of Appeals for the Second Circuit denied an interlocutory appeal (28 U.S.C. §1292) requested by publisher defendants in Heavy, Inc. v. Goldman. The order...

SCOTUS Watch: Supreme Court to Hear Case of What “Registration” Means

On June 28, 2018, the U.S. Supreme Court granted the petition for writ of certiorari in Fourth Estate Pub. Benefit Corp. v. Wall-Street.com, LLC. The justices took up the case to resolve a split in...

Fed Circuit Watch: PTAB Invalidity Collaterally Estops Assertion of Those Claims in Later Appellate Case

The Court of Appeals for the Federal Circuit waded into a convoluted case involving patents directed to X-Y chromosome sorting techniques for selective breeding in livestock. This case is XY, LLC v....

CannabIP: U.S. Patent No. 9,937,147 B2

|

U.S. Patent No. 9,937,147 B2 issued on April 10, 2018, for “Edible Base Product Composition,” to applicant NBDD, Inc., and inventor Doug DeGeeter, of San Francisco, California. The claims are...

Fed Circuit Watch: Walker Process Case Denied En Banc Review

On June 15, 2018, an expanded panel of the Court of Appeals for the Federal Circuit denied petitions for rehearing and rehearing en banc in a per curiam order. This case is Xitronix Corp. v....

SCOTUS Watch: Patent Damages Extends to Foreign Lost Profits

On June 22, 2018, the United States Supreme Court handed down its decision in the case, WesternGeco LLC v. ION Geophysical Corp., which will change the landscape for patent damages because foreign...

CannabIP: FDA Approves First Drug with CBD Active Ingredient

On June 25, 2018, the Food & Drug Administration (FDA) issued a press release in which it approved EPIDIOLEX® for treatment of epilepsy, Lennox-Gastaut syndrome, and Dravet syndrome. Lennox-Gastaut...

CannabIP: U.S. Patent No. 9,901,607 B2

|

U.S. Patent No. 9,901,607 B2 issued on February 27, 2018, to Mark J. Silen, directed to compositions and method of manufacture of preparing and manufacturing smokeless controlled release of...

of 41